|
|
||||||||
Eur J Cardiothorac Surg 2006;29:456-460
© 2006 Elsevier Science NL
a Intensive Care Unit, Henry Dunant Hospital, 107 Mesogeion Ave, 11526 Athens, Greece
b Onassis Cardiac Surgery Center, Athens, Greece
c Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece
d Department of Medicine, Tufts University School of Medicine, Boston, MA, USA
Received 21 March 2005; received in revised form 16 September 2005; accepted 22 December 2005.
* Corresponding author. Address: Intensive Care Unit, Henry Dunant Hospital, 107 Mesogeion Ave, 11526 Athens, Greece. Tel.: +30 210 69 72 353; fax: +30 210 69 72 354. (Email: amichalopoulos{at}hol.gr).
| Abstract |
|---|
|
|
|---|
Key Words: Cardiac surgery Open heart surgery Postoperative complications Nosocomial infection Risk factors
| 1. Introduction |
|---|
|
|
|---|
| 2. Patients and methods |
|---|
|
|
|---|
2.2 Patient population
We studied all adult patients (aged above 16 years) who underwent open heart surgery with the use of extracorporeal circulation over a period of 16 months (June 1996September 1997). Cases were patients who developed microbiologically documented nosocomial infection. Controls were patients who had open heart surgery during two consecutive months of the study period and did not develop nosocomial infection (n
= 314). The selection of this two-month period was done randomly at the beginning of the study (out of eight candidates two-month periods of the whole 16-month study period and it was January and February 1997).
All patients were admitted to the Cardiothoracic ICU (16 beds) immediately following open heart surgery and subsequently transferred to the ward according to the improvement of their medical condition. Patients with pre-existing infection or receipt of antibiotics during the last two days before surgery or pre-existing intra-aortic balloon pump were excluded from the study. Heart transplant recipients, as well as all patients who died in the operating room and in the ICU during the first two postoperative days, were also excluded.
2.3 Data collection
We recorded all the infectious complications that occurred in patients during their ICU and regular ward, regardless of the total length of hospital stay. For each patient we entered data for 20 variables that were considered risk factors for development of nosocomial infection into a database. These were patient-related factors, surgery-related factors, and ICU-related factors.
Patient-related factors included gender, age, preoperative left ventricular ejection fraction assessed by angiography, and New York Heart Association class. We also recorded history of immunosuppression, diabetes mellitus, use of insulin, arterial hypertension, smoking history, pulmonary hypertension, and chronic obstructive pulmonary disease requiring medical therapy with bronchodilators.
Surgery-related factors included the surgical team, type of surgical procedure, combined use of left and right internal mammary artery (LIMA, RIMA) and bypass time. The number of red blood cell units transfused in the operating room or during the first ICU postoperative day, the number of inotropic agents administered during the first postoperative day (for at least 6 h), and the use of intra-aortic balloon counterpulsation and SwanGanz catheter during the first postoperative day. Inotropic drugs were used to treat low cardiac output syndrome, defined as a cardiac index <2 l/min and square body surface meter, despite optimal filling pressures (wedge pressure 12 mmHg). In this situation, dobutamine, adrenaline, dopamine, milrinone, or noradrenaline were given up to their maximum doses. Dopamine at renal doses was not taken into consideration. Red blood cell transfusion was given when the patient's hematocrit was less than 27%.
We also recorded complications that occurred during the early postoperative period in the ICU which theoretically may increase the possibility of nosocomial infection such as low cardiac output syndrome and acute renal failure. Patient outcome evaluated on the day of hospital discharge and the cause(s) of death that occurred during hospitalization were recorded in all patients.
2.4 Managementclinical assessment
Cardiac surgical procedures were performed by three surgical teams. Anesthesia was provided by three teams according to a set protocol. The myocardial protection protocol included the use of antegrade cold crystalloid cardioplegia and antegrade/retrograde cold blood cardioplegia. All patients had at least one central venous catheter. SwanGanz catheter was used only in high risk cardiac surgical patients.
Antibiotic prophylaxis was administered in all patients according to a set protocol. In the patients undergoing coronary artery bypass grafting surgery, cefuroxime was given intravenously as single dose (3 g) at the induction of anesthesia. No additional dose was given in the pump priming solution. In patients who underwent valve replacement surgery or combined coronary artery bypass grafting and valve replacement surgery, a combination of intravenous vancomycin (1 g every 12 h) and netilmicin (150 mg every 12 h) was administered for 24 days. The first doses were given at the induction of anesthesia.
Hematological and biochemical tests, and chest X-rays were performed preoperatively and every day during ICU stay and before discharge. In addition, laboratory tests and X-rays were performed when clinically indicated. All patients were daily evaluated by the intensivists of the Center in order to detect any nosocomial infection. Body temperature was recorded every 1 h in the ICU, every 3 h for the next two days and at least twice daily thereafter. The wounds were examined daily. Bacteriological examinations of blood, tracheal secretions, urine, central venous catheter tips, and of wound swabs were performed in case of a suspected infection.
2.5 Classification of infection
An infection was classified as nosocomial when developed within the hospital and became clinically apparent while the patient was still hospitalized. The infection should not be present or incubating prior to admission to the surgical ICU, occurring after 48 h following admission to the ICU [3,4].
Nosocomial pneumonia was diagnosed based on the presence of the following criteria: fever >38 °C, rales, leukocytosis, detection of new or progressive lung infiltrate(s) not explained otherwise, and purulent respiratory secretion yielding growth of relevant pathogen. A positive culture of blood, pleural fluid, or bronchoalveolar lavage was regarded as additional proof of nosocomial pneumonia [4]. Urinary tract infection was diagnosed in the presence of clinical manifestations such as fever >38 °C, dysuria, or suprapubic tenderness and a positive urine culture, that is, >100,000 microorganisms per cubic centimeter of urine [4].
Infective endocarditis was diagnosed by echocardiography (presence of valve vegetations) combined with compatible clinical signs of infection and positive blood cultures. Central venous catheter-related infection was diagnosed in the presence of bacteremia (with or without the signs of sepsis) that was exclusively attributable to a central venous catheter associated with a count of more than 15 colonies in a semi-quantitative culture of catheter tip (Maki's technique). Primary bloodstream infection was diagnosed in the presence of clinical signs of sepsis plus at least one positive blood culture drawn through a peripheral line in response to unexplained fever of 38.5 °C after the second postoperative day, associated with leukocytosis of >11,000 cm3 or leucopenia of <4000 cm3. The absence of a known focus of infection in another site was necessary for this diagnosis. Diagnosis of sepsis was based on the ACCP/SCCM criteria [5].
Poststernotomy wound infection was defined by clinical evidence of infected presternal tissue and/or sternal osteomyelitis, with or without mediastinal sepsis and with or without unstable sternum. Subtypes included (1) superficial wound infection defined as wound infection confined to the subcutaneous tissue and (2) deep wound infection defined as wound infection associated with sternal osteomyelitis with or without infected retrosternal space. Incisional or deep surgical wound infection was diagnosed based on the following criteria: purulent drainage from the incisional or the drain site, pathogen(s) isolated from wound drainage cultures and signs or symptoms of infection.
Acute renal insufficiency was defined as an absolute abrupt postoperative rise in peak serum creatinine level by 2 mg/dl in a previously normal renal function or a doubling in the admission creatinine level in patients with chronic renal failure [6]. Patients were classified as immunocompromised if they had HIV infection or solid organ transplantation or malignancy or neutropenia (absolute neutrophil count of <1000 mm3) and those receiving corticosteroids (at least 10 mg of prednisone or its equivalent, per day for >14 days prior to surgery) or those received chemotherapy within the past 45 days before surgery.
2.6 Statistical analysis
Data were analyzed using the BMDB Statistical Software (Los Angeles, CA, USA). Tests on categorical variables were based on Pearson chi-square statistics in the case of 2 x 2 tables. Continuous variables were subjected to t-tests with statistical significance confirmed using Welch's method, if appropriate. The variables found to be predictors of nosocomial infection based on univariate analysis were subjected to logistic regression analysis in order to identify a subset of variables for predicting infection. A p-value <0.05 was considered statistically significant.
| 3. Results |
|---|
|
|
|---|
|
Table 2 shows the results of the bivariable analysis of the association of various variables with development of nosocomial infection. Twelve of the original 20 potentially predictive variables had a statistically significant relationship to nosocomial infection. Multivariable logistic regression analysis showed that among all these variables examined, three were independent predictors of nosocomial infection in this group of patients. These were history of immunosuppression (OR = 3.6), transfusion of more than five red blood cell units during the first postoperative day in both the operating room and ICU (OR = 21.2), and development of acute renal failure within the first two days after operation (OR = 49.9) (Table 3 ).
|
|
| 4. Discussion |
|---|
|
|
|---|
Nosocomial infection still remains a diagnostic and therapeutic challenge in the care of cardiac surgery patients. The diagnosis of nosocomial infection in this patient population is sometimes difficult, since clinical and laboratory signs of inflammation may be caused not only by infection, but also by tissue injury and mainly by the systemic inflammatory response syndrome (SIRS) associated with cardiopulmonary bypass. Measurement of CRP could not be demonstrated to clearly help in differentiating between presence and absence of infection in ICU patients [7]. In addition, surgical patients usually receive systemic antibiotics, especially in the ICU, thus negatively influencing blood culture yield [8]. Furthermore, clinical diagnostic criteria for nosocomial pneumonia, central venous catheter-related infection, or bacteremia are non-specific.
Immunosuppression is a documented predisposing factor for development of nosocomial infection [9]. In addition, acute renal failure developed in approximately 4% of patients undergoing cardiac surgery and it is associated with high morbidity and mortality rates [10]. Stallwood et al. [11] recently reported that the use of cardiopulmonary bypass is associated with significantly increased risk of acute renal failure following isolated coronary artery bypass surgery compared to off-pump myocardial revascularization. All efforts are targeting to prevent the development of acute renal failure by better protection of renal function perioperatively.
In addition, any strategy targeting the avoidance of bleeding, and subsequently, of blood transfusion may reduce significantly the incidence of postoperative infection in this group of patients. Regarding the effect of allogeneic blood transfusion on immune function and its association with increased rates of postoperative infections, there are controversial data [1216]. The significance of multiple transfusions on the outcome of patients undergoing myocardial revascularization has been demonstrated [17]. On the other hand, our transfusion trigger (hct below 27) seems to be high. This transfusion trigger was the subject of a recent randomized prospective study suggesting no benefit and possible harm for transfusing at that level [18]. It has been supported that apart from blood transfusion other related factors, such as general anesthesia, hemorrhage, surgical stress, low cardiac output syndrome and/or temporary shock, and possibly systemic inflammatory response syndrome may predispose to immunosuppression and infection [19].
Niederhauser et al. tried to lower infectious complications by administration of prolonged antibiotic prophylaxis in high-risk cardiac surgery patients. They concluded that an additional postoperative prophylaxis regimen with vancomycin and ticarcillin/clavulanate did not reduce the rate of nosocomial infections [20]. For this reason, prolongation of antibiotic prophylaxis is not necessary and sometimes is associated with development of resistant pathogens especially in the ICU setting [21]. On the contrary, the early diagnosis and treatment of postoperative infections is considered very important for the patient's outcome.
Our study has several limitations. First, it is not a matched casecontrol study. Specifically, we used as control patients those who had cardiac operation at the same center during a randomly defined two-month period and did not develop nosocomial infection. However, there are several factors that may influence the development of nosocomial infections in different time periods such as changes in patient population, in staff (especially among doctors and nurses), in hospital and its infection control measures, and changes of the season. Furthermore, potential nosocomial outbreaks of pathogens could also increase the number of nosocomial infections in the studied period of 16 months. Also, we used an old data set in order to identify risk factors of postoperative infection in patients that underwent open heart surgery with use of extracorporeal circulation several years ago, without taking into account the development in the surgical techniques of open heart surgery. For example, several studies have shown that off-pump bypass is associated with a significant reduction in transfusions, inflammatory response, and postoperative infections, especially respiratory tract infections that were the majority of nosocomial infections in our group of patients [22].
In conclusion, we evaluated the frequency and the characteristics of nosocomial infections and we found that a relatively low proportion of these patients developed a microbiologically documented nosocomial infection associated with a notable mortality rate (16.8%). In addition, we found three variables with a statistically significant association with the development of nosocomial-acquired infection during hospitalization in adult patients undergoing open heart surgery by means of cardiopulmonary bypass that could help clinicians to identify uncertain cases of infection.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. S. Rosmarakis, S. N. Prapas, K. Rellos, A. Michalopoulos, G. Samonis, and M. E. Falagas Nosocomial infections after off-pump coronary artery bypass surgery: frequency, characteristics, and risk factors Interactive CardioVascular and Thoracic Surgery, December 1, 2007; 6(6): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mastoraki, A. Michalopoulos, I. Kriaras, and S. Geroulanos Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 442 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Falagas, E. S. Rosmarakis, K. Rellos, A. Michalopoulos, G. Samonis, and S. N. Prapas Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 481 - 490. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |